• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives 17-hydroxysteroids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Hydroxysteroids 17-hydroxysteroids

The Comprehensive Overview of (17a)-3,3-1,2-Ethanediylbis(oxy)-17-hydroxyestra-5(10),9(11)-diene-17-carbonitrile (CAS No. 33300-19-5)

(17a)-3,3-1,2-Ethanediylbis(oxy)-17-hydroxyestra-5(10),9(11)-diene-17-carbonitrile, identified by the CAS registry number 33300-19-5, is a complex organic compound with a unique structure that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of estra-dienes, which are derivatives of estradiol, a naturally occurring steroid hormone. The molecule features a bicyclic framework with multiple functional groups, including hydroxyl and cyano groups, which contribute to its diverse chemical properties and potential biological activities.

The chemical structure of (17a)-3,3-1,2-Ethanediylbis(oxy)-... is characterized by a rigid framework with conjugated double bonds and hydroxyl groups positioned at specific sites. The presence of the cyano group at the 17th position introduces additional functionality, potentially influencing the compound's reactivity and bioavailability. Recent studies have highlighted the importance of such structural features in modulating the pharmacokinetic properties of steroid derivatives.

From a synthetic perspective, the preparation of this compound involves multi-step reactions that require precise control over stereochemistry and regioselectivity. Researchers have employed various methodologies, including oxidation-reduction sequences and ring-closing reactions, to construct the complex bicyclic system. The development of efficient synthetic routes has been a focal point in recent literature, driven by the demand for scalable production methods for potential therapeutic agents.

In terms of biological activity, (17a)-... has been investigated for its potential as an anti-inflammatory and anti-proliferative agent. Preclinical studies have demonstrated its ability to inhibit key enzymes involved in inflammatory pathways, suggesting its potential application in treating chronic inflammatory diseases. Furthermore, recent research has explored its effects on cellular proliferation in cancer models, revealing promising results that warrant further investigation in clinical settings.

The pharmacokinetic profile of this compound has also been extensively studied. Findings indicate that the hydroxyl and cyano groups play a significant role in determining its absorption, distribution, metabolism, and excretion (ADME) properties. These studies have provided valuable insights into optimizing drug delivery systems for enhanced bioavailability and reduced toxicity.

Looking ahead, the continued exploration of (17a)-...'s chemical and biological properties is expected to yield novel applications in drug discovery and development. Collaborative efforts between chemists and pharmacologists are likely to uncover new therapeutic potentials for this compound, particularly in areas such as oncology and inflammation management.

In conclusion, (17a)-... (CAS No. 33300-19-5) stands as a testament to the intricate relationship between chemical structure and biological function. With ongoing advancements in synthetic methodologies and pharmacological research, this compound continues to be a subject of intense scientific interest and holds promise for future therapeutic innovations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)